Correlation Engine 2.0
Clear Search sequence regions

  • auc (1)
  • chest discomfort (1)
  • cTnT (6)
  • diagnosis (5)
  • emergency (1)
  • help (1)
  • humans (1)
  • patients (4)
  • prognostic (2)
  • st- segment (2)
  • troponin (8)
  • Sizes of these terms reflect their relevance to your search.

    Glucose is a universally available inexpensive biomarker, which is increased as part of the physiological stress response to acute myocardial infarction (AMI) and may therefore help in its early diagnosis. To test this hypothesis, glucose, high-sensitivity cardiac troponin (hs-cTn) T, and hs-cTnI were measured in consecutive patients presenting with acute chest discomfort to the emergency department (ED) and enrolled in a large international diagnostic study (NCT00470587). Two independent cardiologists centrally adjudicated the final diagnosis using all clinical data, including serial hs-cTnT measurements, cardiac imaging and clinical follow-up. The primary diagnostic endpoint was index non-ST-segment elevation MI (NSTEMI). Prognostic endpoints were all-cause death, and cardiovascular (CV) death or future AMI, all within 730-days. Among 5639 eligible patients, NSTEMI was the adjudicated final diagnosis in 1051 (18.6%) patients. Diagnostic accuracy quantified using the area under the receiver-operating characteristics curve (AUC) for the combination of glucose with hs-cTnT and glucose with hs-cTnI was very high, but not higher versus that of hs-cTn alone (glucose/hs-cTnT 0.930 [95% CI 0.922-0.937] versus hs-cTnT 0.929 [95% CI 0.922-0.937]; glucose/hs-cTnI 0.944 [95% CI 0.937-0.951] versus hs-cTnI 0.944 [95% CI 0.937-0.951]). In early-presenters, a dual-marker strategy (glucose < 7 mmol/L and hs-cTnT < 5/hs-cTnI < 4 ng/L) provided very high and comparable sensitivity to slightly lower hs-cTn concentrations (cTnT/I < 4/3 ng/L) alone, and possibly even higher efficacy. Glucose was an independent predictor of 730-days endpoints. Our results showed that a dual marker strategy of glucose and hs-cTn did not increase the diagnostic accuracy when used continuously. However, a cutoff approach combining glucose and hs-cTn may provide diagnostic utility for patients presenting ≤ 3 h after onset of symptoms, also providing important prognostic information. © 2023. Springer Nature Limited.


    Ana Yufera-Sanchez, Pedro Lopez-Ayala, Thomas Nestelberger, Karin Wildi, Jasper Boeddinghaus, Luca Koechlin, Maria Rubini Gimenez, Hüseyin Sakiz, Paolo Bima, Oscar Miro, F Javier Martín-Sánchez, Michael Christ, Dagmar I Keller, Danielle M Gualandro, Damian Kawecki, Katharina Rentsch, Andreas Buser, Christian Mueller, APACE Investigators. Combining glucose and high-sensitivity cardiac troponin in the early diagnosis of acute myocardial infarction. Scientific reports. 2023 Sep 05;13(1):14598

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 37670005

    View Full Text